ProfileGDS5678 / 1459879_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 70% 67% 68% 68% 70% 69% 68% 68% 68% 68% 68% 68% 68% 67% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 14.3585970
GSM967853U87-EV human glioblastoma xenograft - Control 24.0632867
GSM967854U87-EV human glioblastoma xenograft - Control 34.1182568
GSM967855U87-EV human glioblastoma xenograft - Control 44.2322168
GSM967856U87-EV human glioblastoma xenograft - Control 54.3754270
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 14.2468769
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 24.1809268
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 34.1291968
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 44.1401368
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 14.1574868
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 24.1370768
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 34.1265568
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 44.1404268
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 54.0278767